Form Type: 4

SEC EDGAR Link
Accession Number:0001192482-19-000248
Date:2019-05-09
Issuer: RECRO PHARMA, INC. (REPH)
Original Submission Date:

Reporting Person:

ASHTON WILLIAM
C/O RECRO PHARMA, INC.
490 LAPP ROAD MALVERN, PA 19355

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-05-09 A 7,955 a $0.00 27,412 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 8.8 2019-05-09 deemed execution date A 10,888 (a) 2029-05-09 common stock 10,888 $8.80 10,888 direct
Footnotes
IDfootnote
f1 all shares of common stock are represented by unvested restricted stock units that will vest on may 9, 2020. vested shares will be delivered to the reporting person within 30 days following the vesting date.
f2 the stock option will vest on may 9, 2020.
WhaleWisdom Logo

Elevate your investments